Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sotera Health (SHC) EBIT (2020 - 2025)

Sotera Health has reported EBIT over the past 6 years, most recently at $108.4 million for Q4 2025.

  • Quarterly results put EBIT at $108.4 million for Q4 2025, up 24.4% from a year ago — trailing twelve months through Dec 2025 was $392.8 million (up 31.97% YoY), and the annual figure for FY2025 was $392.8 million, up 31.97%.
  • EBIT for Q4 2025 was $108.4 million at Sotera Health, down from $114.3 million in the prior quarter.
  • Over the last five years, EBIT for SHC hit a ceiling of $114.3 million in Q3 2025 and a floor of $33.4 million in Q1 2023.
  • Median EBIT over the past 5 years was $71.9 million (2022), compared with a mean of $73.6 million.
  • Peak annual rise in EBIT hit 72.89% in 2023, while the deepest fall reached 37.62% in 2023.
  • Sotera Health's EBIT stood at $66.4 million in 2021, then decreased by 9.42% to $60.2 million in 2022, then surged by 72.89% to $104.0 million in 2023, then decreased by 16.23% to $87.1 million in 2024, then grew by 24.4% to $108.4 million in 2025.
  • The last three reported values for EBIT were $108.4 million (Q4 2025), $114.3 million (Q3 2025), and $97.7 million (Q2 2025) per Business Quant data.